CALA (Calithera Biosciences) Beginning Cash Position: $34.32 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Calithera Biosciences Beginning Cash Position?

Calithera Biosciences CALA Beginning Cash Position is $34.32 Mil as of Dec. 2022.

Calithera Biosciences's Beginning Cash Position for the quarter that ended in Dec. 2022 was $34.32 Mil.

Calithera Biosciences's quarterly Beginning Cash Position declined from Jun. 2022 ($44.93 Mil) to Sep. 2022 ($42.06 Mil) and declined from Sep. 2022 ($42.06 Mil) to Dec. 2022 ($34.32 Mil).

Calithera Biosciences's annual Beginning Cash Position increased from Dec. 2020 ($60.88 Mil) to Dec. 2021 ($107.59 Mil) but then declined from Dec. 2021 ($107.59 Mil) to Dec. 2022 ($59.81 Mil).

Calithera Biosciences Beginning Cash Position Related Terms

Calithera Biosciences Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Calithera Biosciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Calithera Biosciences Beginning Cash Position Chart

Calithera Biosciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.92 51.50 60.88 107.59 59.81

Calithera Biosciences Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.76 59.81 44.93 42.06 34.32

Calithera Biosciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $34.32 Mil mean?
Calithera Biosciences (CALA) has a Beginning Cash Position of $34.32 Mil as of Dec. 2022. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Calithera Biosciences and its competitors.
Is Calithera Biosciences' Beginning Cash Position too high?
Calithera Biosciences' current Beginning Cash Position is $34.32 Mil.
How does Calithera Biosciences' Beginning Cash Position compare to PPCB and QBIO?
Calithera Biosciences' Beginning Cash Position of $34.32 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Diversified Financial Services company?
A good Beginning Cash Position depends on the Diversified Financial Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Calithera Biosciences and its competitors. Calithera Biosciences's current Beginning Cash Position is $34.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calithera Biosciences stock overvalued right now?
Calithera Biosciences (CALA) has a current Beginning Cash Position of $34.32 Mil. The current Beginning Cash Position is $34.32 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Calithera Biosciences (CALA), the current Beginning Cash Position is $34.32 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Calithera Biosciences Business Description

Address 343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080
Calithera Biosciences Inc is a shell company.